2023-19179. Bulk Manufacturer of Controlled Substances Application: SpecGx LLC; Correction  

  • Start Preamble

    AGENCY:

    Drug Enforcement Administration, Justice.

    ACTION:

    Notice; correction.

    SUMMARY:

    The Drug Enforcement Administration (DEA) published a document in the Federal Register of April 4, 2023, concerning a notice of application for bulk manufacturer of Controlled Substances. That document listed a drug code/controlled substance in error as it was not requested by the registrant (2270—Pentobarbital). Additionally, the document listed duplicates of 7 other drug codes in error (1100, 1105, 1205, 1724, 8333, 9780, 9801).

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    Correction

    In the Federal Register of April 4, 2023, in FR Doc. 2023–06952 (88 FR 19990), on page 19990, in columns 1 and 2, under the requested controlled substances/drug codes, it should read as such:

    Controlled substanceDrug codeSchedule
    Gamma Hydroxybutyric Acid2010I
    Tetrahydrocannabinols7370I
    Psilocybin7437I
    Codeine-N-oxide9053I
    Noroxymorphone9145I
    Difenoxin9168I
    Morphine-N-oxide9307I
    Normorphine9313I
    Alphamethadol9605I
    Betamethadol9609I
    Norlevorphanol9634I
    Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)9821I
    Butyryl Fentanyl9822I
    Fentanyl related-compounds as defined in 21 CFR 1308.11(h)9850I
    Amphetamine1100II
    Methamphetamine1105II
    Lisdexamfetamine1205II
    Methylphenidate1724II
    Nabilone7379II
    ANPP (4-Anilino-N-phenethyl-4-piperidine)8333II
    Phenylacetone8501II
    Codeine9050II
    Dihydrocodeine9120II
    Oxycodone9143II
    Hydromorphone9150II
    Diphenoxylate9170II
    Ecgonine9180II
    Hydrocodone9193II
    Levorphanol9220II
    Isomethadone9226II
    Meperidine9230II
    Meperidine intermediate-A9232II
    Meperidine intermediate-B9233II
    Meperidine intermediate-C9234II
    Methadone9250II
    Methadone intermediate9254II
    Dextropropoxyphene, bulk (non-dosage forms)9273II
    Morphine9300II
    Oripavine9330II
    Thebaine9333II
    Opium tincture9630II
    Start Printed Page 60988
    Opium, powdered9639II
    Oxymorphone9652II
    Noroxymorphone9668II
    Alfentanil9737II
    Remifentanil9739II
    Sufentanil9740II
    Tapentadol9780II
    Fentanyl9801II
    Start Signature

    Claude Redd,

    Acting Deputy Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2023–19179 Filed 9–5–23; 8:45 am]

    BILLING CODE P

Document Information

Published:
09/06/2023
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice; correction.
Document Number:
2023-19179
Pages:
60987-60988 (2 pages)
Docket Numbers:
Docket No. DEA-1176
PDF File:
2023-19179.pdf